Haemonetics (HAE) Expands VASCADE Line With New Limited Launch [Yahoo! Finance]
Haemonetics Corporation (HAE)
Last haemonetics corporation earnings: 2/4 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=72118&p=irol-irhome
Company Research
Source: Yahoo! Finance
The device comes with innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis. The latest development is expected to help Haemonetics grab opportunities in the growing vascular closure solutions space. About VASCADE MVP XL VASCADE MVP XL system is designed for "mid-bore" multi-access femoral venous closure with 6-12F procedural sheaths. The new VASCADE MVP XL system is expected to provide a robust closure solution for procedures requiring 10-12F sheath (up to 15F in outer diameter) by utilizing 58% more collagen and a larger disc compared with the current VASCADE system. Earlier this year, VASCADE MVP XL system gained pre-market approval from the U.S. Food and Drug Administration. More on the News The launch of VASCADE MVP XL should expand Haemonetics' VASCADE portfolio of vascular closure systems. HAE's current VASCADE portfolio includes the VASCADE system, intended for "small-bore" femoral arterial and venou
Show less
Read more
Impact Snapshot
Event Time:
HAE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HAE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HAE alerts
High impacting Haemonetics Corporation news events
Weekly update
A roundup of the hottest topics
HAE
News
- Is Haemonetics Corporation (HAE) an Undervalued Healthcare Stock to Buy in 2025 [Yahoo! Finance]Yahoo! Finance
- Haemonetics Co. (NYSE: HAE) is now covered by analysts at CL King. They set a "buy" rating and a $116.00 price target on the stock.MarketBeat
- Haemonetics Co. (NYSE: HAE) is now covered by analysts at Bank of America Co.. They set a "neutral" rating and a $85.00 price target on the stock.MarketBeat
- Haemonetics Co. (NYSE: HAE) is now covered by analysts at BTIG Research. They set a "buy" rating and a $112.00 price target on the stock.MarketBeat
- Global Blood Collection Market Size To Worth USD 24.90 Billion By 2033 | CAGR of 8.02% [Yahoo! Finance]Yahoo! Finance
HAE
Earnings
- 8/9/24 - Miss
HAE
Sec Filings
- 9/18/24 - Form 4
- 9/16/24 - Form 8-K
- 9/3/24 - Form 4
- HAE's page on the SEC website